(Q58855397)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10680969%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Evaluation of different measles IgG assays based on recombinant proteins using a panel of low-titre sera (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10680969%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10680969%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

F Hanses

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10680969%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

F Schneider

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10680969%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H K Hartter

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10680969%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H W Vos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10680969%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

F B Bouche

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10680969%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A D Osterhaus

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10680969%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

C P Muller

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10680969%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10680969%20AND%20SRC:MED&resulttype=core&format=json

Journal of Virological Methods

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10680969%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10680969%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10680969%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

191-200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10680969%20AND%20SRC:MED&resulttype=core&format=json

Role of virus strain dm conventional and enhanced measles plaque neutralization test

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

Secondary measles vaccine failure in healthcare workers exposed to infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

Enzyme-linked immunosorbent assay for detection of measles antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

A simplified immunoassay based on measles virus recombinant hemagglutinin protein for testing the immune status of vaccinees

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

Measles antibody: reevaluation of protective titers

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

Estimated susceptibility to asymptomatic secondary immune response against measles in late convalescent and vaccinated persons.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

Measles virus fusion protein- and hemagglutinin-transfected cell lines are a sensitive tool for the detection of specific antibodies by a FACS-measured immunofluorescence assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

The 1st International Standard for anti-measles serum.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

A modified ROC analysis for the selection of cut-off values and the definition of intermediate results of serodiagnostic tests

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

An evaluation of nine commercial EIA kits for the detection of measles specific IgG

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

Measles and rubella in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

Characteristics of asymptomatic secondary immune responses to measles virus in late convalescent donors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

The use of mathematical models in the epidemiological study of infectious diseases and in the design of mass immunization programmes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

Measles, mumps, and rubella vaccine: what coverage to block transmission?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

Differences in the Appearance of Antibodies to Structural Components of Measles Virus after Immunization with Inactivated and Live Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among revaccinees

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

Computer-assisted rapid enzyme-linked immunosorbent assay (ELISA) in the serological diagnosis of aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

ROC curves and the areas under them for dichotomized tests: empirical findings for logistically and normally distributed diagnostic test results.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900143-3

7 January 2021

10.1016/S0166-0934(99)00143-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10680969%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference